Y-175L

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameY-175L
Drug Alias NameFcgR1 Inhibitor (Azano)Y-175L
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHigh affinity immunoglobulin gamma Fc receptor I modulators
TargetsHigh affinity immunoglobulin gamma Fc receptor I
Therapy Area/IndicationsLupus Nephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAzano Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAzano Biotech
Active IndicationsN/A
Inactive IndicationsLupus Nephritis

Other Information

ATC CodeN/A
Related LinksN/A